CSIMarket
 


Cure Pharmaceutical Holding Corp   (CURR)
Other Ticker:  
 
 

CURR's Revenue Growth by Quarter and Year

Cure Pharmaceutical Holding 's Revenue results by quarter and year




CURR Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 0.00 0.00 0.00
III Quarter September 1.78 0.00 0.00 0.00
II Quarter June 1.12 0.00 0.00 0.00
I Quarter March 1.10 0.00 0.00 0.00
FY   4.00 0.00 0.00 0.00



CURR Revenue third quarter 2022 Y/Y Growth Comment
Cure Pharmaceutical Holding Corp in the third quarter 2022 achieved Revenue of $ 1.78 millions compare to recorded in same quarter a year ago.

Looking into third quarter 2022 results within Major Pharmaceutical Preparations industry 43 other companies have achieved higher Revenue growth. While Cure Pharmaceutical Holding Corp ' s Revenue no change of % ranks overall at the positon no. 266 in the third quarter 2022.




CURR Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cure Pharmaceutical Holding 's third quarter 2022 Revenue $ 1.78 millions CURR's Income Statement
Cure Pharmaceutical Holding 's third quarter 2021 Revenue $ 0.00 millions Quarterly CURR's Income Statement
New: More CURR's historic Revenue Growth >>


CURR Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September 59.29 % - - -
II Quarter June 1.82 % - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #44
Healthcare Sector #80
Overall #266

Revenue Y/Y Growth Statistics
High Average Low
58.86 % 30.34 % 1.81 %
(Sep 30 2022)   (Jun 30 2022)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #44
Healthcare Sector #80
Overall #266
Revenue Y/Y Growth Statistics
High Average Low
58.86 % 30.34 % 1.81 %
(Sep 30 2022)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Cure Pharmaceutical Holding 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
58.86 % 30.34 % 1.81 %
(Sep 30 2022)  


CURR's III. Quarter Q/Q Revenue Comment
Cure Pharmaceutical Holding Corp achieved in the III. Quarter 2022 above company average sequential Revenue jump of 59.29%, to $ 1.78 millions, from $1.12 millions in the second quarter.
CURR is impressively improving, not only claiming above regular growth, but also improving rate, Devin E. Baker, Healthcare sector advisor mentioned.

Within Major Pharmaceutical Preparations industry 43 other companies have achieved higher Revenue quarter on quarter growth. While Cure Pharmaceutical Holding 's Revenue growth quarter on quarter, overall rank is 266.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #44
Healthcare Sector #80
Overall #266
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #44
Healthcare Sector #80
Overall #266
Revenue Q/Q Growth Statistics
High Average Low
58.86 % 30.34 % 1.81 %
(Sep 30 2022)  


CURR's III. Quarter Q/Q Revenue Comment
Cure Pharmaceutical Holding Corp achieved in the III. Quarter 2022 above company average sequential Revenue jump of 59.29%, to $ 1.78 millions, from $1.12 millions in the second quarter.
Major Pharmaceutical Preparations company is going from strength to strength, not just reporting better then average increase, and also improving pace.

Within Major Pharmaceutical Preparations industry 43 other companies have achieved higher Revenue quarter on quarter growth. While Cure Pharmaceutical Holding 's Revenue growth quarter on quarter, overall rank is 266.


Cure Pharmaceutical Holding 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Sep 30 2022 period, Cure Pharmaceutical Holding 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Cure Pharmaceutical Holding Corp achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Sep 30 2022 period, Cure Pharmaceutical Holding 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Cure Pharmaceutical Holding Corp achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CURR's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CURR's Competitors
Revenue Growth for Cure Pharmaceutical Holding 's Suppliers
Revenue Growth for CURR's Customers

You may also want to know
CURR's Annual Growth Rates CURR's Profitability Ratios CURR's Asset Turnover Ratio CURR's Dividend Growth
CURR's Roe CURR's Valuation Ratios CURR's Financial Strength Ratios CURR's Dividend Payout Ratio
CURR's Roa CURR's Inventory Turnover Ratio CURR's Growth Rates CURR's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Owens and Minor Inc -0.19%$ -0.191 millions
National Research Corporation-0.20%$ -0.201 millions
Livanova Plc-0.24%$ -0.241 millions
Healthcare Services Group Inc -0.27%$ -0.265 millions
Catalent Inc -0.29%$ -0.293 millions
Asensus Surgical Inc -0.31%$ -0.311 millions
Liquidia Corporation-0.43%$ -0.429 millions
Integra Lifesciences Holdings Corp-0.43%$ -0.432 millions
Pediatrix Medical Group Inc -0.62%$ -0.615 millions
China Pharma Holdings Inc -0.64%$ -0.642 millions
Acadia Pharmaceuticals Inc -0.68%$ -0.682 millions
Syneos Health Inc -0.89%$ -0.891 millions
Innovage Holding Corp -1.07%$ -1.070 millions
Procyon Corp-1.20%$ -1.200 millions
Precipio inc -1.38%$ -1.380 millions
Ati Physical Therapy Inc -1.40%$ -1.397 millions
Ocular Therapeutix Inc -1.55%$ -1.547 millions
Alpine Immune Sciences Inc -1.75%$ -1.750 millions
Surgalign Holdings Inc -1.79%$ -1.786 millions
Tenet Healthcare Corp-1.90%$ -1.900 millions
Teleflex Incorporated-1.92%$ -1.923 millions
Novocure Limited-1.95%$ -1.952 millions
Dynatronics Corporation-2.01%$ -2.014 millions
Royalty Pharma Plc-2.10%$ -2.101 millions
National Healthcare Corp-2.13%$ -2.130 millions
Fonar Corporation-2.27%$ -2.271 millions
Psychemedics Corp-2.35%$ -2.353 millions
Escalon Medical Corp -2.63%$ -2.626 millions
Lifevantage Corp-2.72%$ -2.724 millions
West Pharmaceutical Services Inc -2.77%$ -2.774 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ISPO's Profile

Stock Price

ISPO's Financials

Business Description

Fundamentals

Charts & Quotes

ISPO's News

Suppliers

ISPO's Competitors

Customers & Markets

Economic Indicators

ISPO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071